Post Profile

mTOR and the Age-Related Decline in Stem Cell Activity

As a companion piece to an earlier post on the relationship between the mechanistic target of rapamycin (mTOR) gene and cellular senescence in aging, you might take a look at the research here that investigates the relationship between mTOR and the characteristic decline in stem cell activity that occurs with advancing age. In addition to the large body of research focused on insulin and growth hormone metabolism, work on mTOR is among the most active areas of study resulting from investigations of calorie restriction.
read more


Related Posts

Decreased mTOR Expression Provides 20% Mean Life Span Extension in Mice

Health / Aging : Fight Aging

Mammalian (or mechanistic, depending on who you ask) target of rapamycin (mTOR) is the most likely candidate for the next round of billion-dollar research funding devoted to the search for drugs that can slow aging. It will be a rep...

Cellular Senescence and Stem Cell Decline in Age-Related Cardiac Hypertrophy Caused by Hypertension

Health / Aging : Fight Aging

Cellular senescence is one of the causes of aging; senescent cells accumulate in tissues, and their inflammatory and other disruptive signaling causes considerable harm. With the newfound and rapidly spreading interest in senescent ...

The Roles of mTOR in Aging

Health / Aging : Fight Aging

Next to insulin signaling, the biochemistry surrounding mechanistic target of rapamycin (mTOR) is probably the greatest point of study for that part of the mainstream research community interested in modestly slowing aging through p...

Cellular Senescence and Stem Cell Aging

Health / Aging : Fight Aging

In recent years, researchers have provided evidence to suggest that cellular senescence mechanisms are partly involved in the decline of stem cell activity in aging. It is an open question as to how this interacts with other signali...

Looking Beyond Rapamycin at the Effects of Other Anti-Cancer Agents on Aging

Health / Aging : Fight Aging

There is some debate over whether rapamycin, an immune suppressant agent that is presently being used in research to inhibit the activities of the protein produced by the mechanistic target of rapamycin (mTOR) gene, causes a slowing...


Copyright © 2016 Regator, LLC